Answer
Breastfeeding should be discontinued during treatment with Reagila (cariprazine hydrochloride), because excretion into human milk is unknown and a risk to newborns or infants cannot be excluded.
Sources for this answer
- Reagila 1.5 mg 3 mg 4.5 mg 6 mg hard capsulesGedeon Richter (UK) Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked